share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga Real-time News ·  Jan 25, 2023 08:08

Gainers

  • Sonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 80.0% to $2.16 during Wednesday's pre-market session. The company's market cap stands at $6.7 million.
  • First Wave BioPharma (NASDAQ:FWBI) stock moved upwards by 28.05% to $5.66. The market value of their outstanding shares is at $5.6 million.
  • Incannex Healthcare (NASDAQ:IXHL) stock increased by 23.74% to $3.96. The company's market cap stands at $241.3 million.
  • Aridis Pharmaceuticals (NASDAQ:ARDS) shares increased by 17.85% to $0.99. The market value of their outstanding shares is at $25.7 million.
  • INmune Bio (NASDAQ:INMB) shares moved upwards by 17.33% to $8.8. The company's market cap stands at $157.9 million.
  • Creative Medical Tech (NASDAQ:CELZ) stock increased by 13.72% to $0.58. The market value of their outstanding shares is at $8.1 million.

Losers

  • Axcella Health (NASDAQ:AXLA) stock decreased by 23.3% to $0.46 during Wednesday's pre-market session. The company's market cap stands at $33.8 million.
  • Precigen (NASDAQ:PGEN) shares declined by 17.36% to $1.81. The market value of their outstanding shares is at $376.7 million.
  • Finch Therapeutics Group (NASDAQ:FNCH) stock declined by 17.16% to $0.41. The market value of their outstanding shares is at $19.6 million.
  • Calithera Biosciences (NASDAQ:CALA) shares fell 13.47% to $0.4. The company's market cap stands at $1.9 million.
  • Baudax Bio (NASDAQ:BXRX) stock fell 10.79% to $3.72. The market value of their outstanding shares is at $2.0 million.
  • Intuitive Surgical (NASDAQ:ISRG) shares declined by 8.91% to $235.0. The market value of their outstanding shares is at $83.0 billion. As per the press release, Q4 earnings came out yesterday. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment